IRCT20100127003200N6招募中3 期
Safety and efficacy of Anti-Thymocyte Globulin (Zist Kowsar Pharmaceutical Company) in comparison with Anti-Thymocyte Globulin (Genzyme) for immunosuppressive induction therapy in adults with renal transplantation: A phase III, randomized, parallel, single blind , non-inferiority design
Kowsar Biotechnology company0 个研究点目标入组 129 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 129
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age >18 years (donor age >= 5) for recipient
- •ability and willingness to sign the informed consent
- •Reception of kidney from cadaver OR second graft (already rejected a kidney more than 6-12 month ago) OR indication for receiving the investigated drug
排除标准
- •Positive history of polyclonal Anti-T-Cell therapy
- •Known allergy to Rabbit proteins
- •Positive history of malignancy in 2 years( excluding stem cell , squamous cell, bladder malignancies and asymptomatic invasive papillary renal cell cancer with less than 5 cm size)
- •Lactating mother
- •Willingness to pregnancy and not using a safe contraceptive method
- •Positive serology for: HTLV, HIV or HBV
研究者
相似试验
尚未招募
不适用
The effects of antithymocyte globulin (ATG) on the endothelial glycocalyx in kidney transplant recipientsendothelial glycocalyx and atherosclerosis1003843010003216NL-OMON34735Academisch Medisch Centrum6
已完成
不适用
Safety and efficacy of thymoglobulin (ATG) for cord blood transplantation for hematologic malignanciesHematologic malignancies with an indication for allogeneic hematopoietic stem cell transplantation (allo- HSCT) Acute myeloid leukemia Myelodysplastic syndrome Chronic myeloid leukemia Malignant lymphoma Acute lymphoblastic leukemiaJPRN-UMIN000004206Hematology, Osaka City University, Graduate School of Meicine7
已完成
不适用
Thymoglobulin for chronic graft-versus-host disease prophylaxisNeoplasmsKCT0002291The Catholic University of Korea, Seoul St. Mary's Hospital126
尚未招募
不适用
Anti-thymocyte globulin, cyclosporine A and Low-dose danazoL for Idiopathic Untreated Moderate to severe aplastic anemiaKCT0004219Gachon University Gil Medical Center73
尚未招募
2 期
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 BlockadeGraft-versus-host DiseaseHematological MalignanciesNCT06238245Beijing 302 Hospital22